You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》微創醫療(00853.HK)分拆微創腦科學 傳籌5,000萬美元
阿思達克 06-20 10:00
據《路透社》旗下IFR引述消息人士指,微創醫療(00853.HK)分拆旗下的微創腦科學,已於今日(20日)啟動預路演,以了解機構投資者意向,預期將集資約5,000萬美元。聯席保薦人為摩根大通及中金公司。 微創腦科學已於近日通過聯交所上市聆訊,聆訊後資料顯示,微創腦科學為中國神經介入醫療器械公司,現時共擁有30款產品,包括在中國獲得批准並商業化的10款治療產品及3款通路產品,以及17款正在開發的候選產品,涵蓋神經血管疾病領域。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account